Additional clinical studies are planned for ALS; Alzheimer’s, Huntington’s, MS, and other neurodegenerative diseases; Cancer; Complex Regional Pain Syndrome; Diabetes; HIV/AIDs; Parkinson’s Disease; and Rheumatoid Arthritis and other auto-immune diseases.
ALS: Imbalanced ROx at the motor neuron leads to oxidative damage to the motor neuron and surrounding tissue.
Alzheimer’s, Huntington’s, MS, and other neurodegenerative diseases: Imbalanced ROx, for nervous system operation and signaling, leads to oxidative damage of nerve tissue and surrounding tissue..
Cancer: A tumor cannot be contained if there is insufficient ROx. A cancer patient with sufficient ROx can prevent a tumor from spreading by destroying any metastasized cancer cells.
Complex Regional Pain Syndrome (CRPS): Out of balance ROx allows free radicals to send unexplained pain signals to the brain.
Diabetes: If not enough ROx is delivered for glucose to be converted to energy, more insulin will be required to control a person’s sugar level.
HIV/AIDs: When a T-cell recognizes a virus, it recruits a critical mass of ROx to destroy the virus. Insufficient ROx leads to the premature release of oxygen, destroying T-cells and surrounding tissues.
Parkinson’s Disease: Only about 30% of people with the gene for Parkinson’s Disease (PD) actually get the disease. If less than a critical mass of ROx exists, radicals will be released in the brain and the surrounding tissues, resulting in widespread damage and causing a chain of events that leads to PD.
Rheumatoid Arthritis (RA) and other auto-immune diseases: Insufficient ROx allows for the indiscriminate spread of radical oxygen species, thus damaging surrounding tissues.